Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer

Madoka Kimura, Tateaki Naito, Hirotsugu Kenmotsu, +14

Supportive Care in Cancer

Prognostic ImpactCancer CachexiaMedicineCancer ManagementPathology +7

Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study

Hirotsugu Kenmotsu, Kazushige Wakuda, Keita Mori, +16

Journal of Thoracic Oncology

Rebiopsy for patients with non‐small‐cell lung cancer after epidermal growth factor receptor‐tyrosine kinase inhibitor failure

Takahisa Kawamura, Hirotsugu Kenmotsu, Tetsuhiko Taira, +11

Cancer Science

Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer

Tateaki Naito, Taro Okayama, Takashi Aoyama, +20

BMC Cancer

Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease

Hirotsugu Kenmotsu, Tateaki Naito, Keita Mori, +8

Cancer Chemotherapy and Pharmacology

MedicinePathologyMetronomic ChemotherapyCancer TreatmentOncology +3

A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)

Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, +17

Journal of Thoracic Oncology

Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study

Tateaki Naito, Taro Okayama, Takashi Aoyama, +20

BMC Cancer

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis

Giovenzio Genestreti, Marcello Tiseo, Hirotsugu Kenmotsu, +13

Clinical Lung Cancer

Platinum/etoposide RechallengeMulti-institutional Retrospective AnalysisAdvanced Lung DiseaseMedicineCancer Management +7

Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases

Eriko Miyawaki, Hirotsugu Kenmotsu, Keita Mori, +15

International Journal of Radiation Oncology*Biology*Physics

Optimal SequenceBrain MetastasesMedicinePathologyBronchial Neoplasm +6

Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC

Taichi Miyawaki, Tateaki Naito, Akihro Kodama, +16

JTO Clinical and Research Reports